XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT06568562 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer

Interventions

DRUG: XL092

Sponsor

University of Utah

Collaborators

[object Object]